SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning ""Bob" ;lar1:(gu)"

Sökning: "Bob" > Göteborgs universitet

  • Resultat 1-10 av 116
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Argiropoulos, Bob, et al. (författare)
  • Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3.
  • 2008
  • Ingår i: Experimental hematology. - : Elsevier BV. - 0301-472X. ; 36:7, s. 845-59
  • Tidskriftsartikel (refereegranskat)abstract
    • OBJECTIVE: MEIS1, a HOX cofactor, collaborates with multiple HOX and NUP98-HOX fusion proteins to accelerate the onset of acute myeloid leukemia (AML) through largely unknown molecular mechanisms. MATERIALS AND METHODS: To further resolve these mechanisms, we conducted a structure-function analysis of MEIS1 and gene-expression profiling, in the context of NUP98-HOXD13 (ND13) leukemogenesis. RESULTS: We show, in a murine bone marrow transplantation model, that the PBX-interaction domain, the homeodomain, and the C-terminal domain of MEIS1, are all required for leukemogenic collaboration with ND13. In contrast, the N-terminal domain of MEIS1 is dispensable for collaboration with ND13, but is required for Flt3 upregulation, indicating additional roles for MEIS1 in induction of leukemia independent of alterations in Flt3 expression. Gene-expression profiling of a cloned ND13 preleukemic cell line transduced with wild-type or Meis1 mutant forms revealed deregulation of multiple genes, including a set not previously implicated as MEIS1 targets. Chromatin immunoprecipitation revealed the in vivo occupancy of MEIS1 on regulatory sequences of Trib2, Flt3, Dlk1, Ccl3, Ccl4, Pf4, and Rgs1. Furthermore, engineered overexpression of Trib2 complements ND13 to induce AML while Ccl3 potentiates the repopulating ability of ND13. CONCLUSION: This study shows that Meis1-induced leukemogenesis with ND13 can occur in the absence of Flt3 upregulation and reveals the existence of other pathways activated by MEIS1 to promote leukemia.
  •  
2.
  • Argiropoulos, Bob, et al. (författare)
  • Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.
  • 2010
  • Ingår i: Blood. - : American Society of Hematology. - 1528-0020 .- 0006-4971. ; 115:20, s. 4071-82
  • Tidskriftsartikel (refereegranskat)abstract
    • MEIS1 is a three-amino acid loop extension class homeodomain-containing homeobox (HOX) cofactor that plays key roles in normal hematopoiesis and leukemogenesis. Expression of Meis1 is rate-limiting in MLL-associated leukemias and potently interacts with Hox and NUP98-HOX genes in leukemic transformation to promote self-renewal and proliferation of hematopoietic progenitors. The oncogenicity of MEIS1 has been linked to its transcriptional activation properties. To further reveal the pathways triggered by Meis1, we assessed the function of a novel engineered fusion form of Meis1, M33-MEIS1, designed to confer transcriptional repression to Meis1 target genes that are otherwise up-regulated in normal and malignant hematopoiesis. Retroviral overexpression of M33-Meis1 resulted in the rapid and complete eradication of M33-Meis1-transduced normal and leukemic cells in vivo. Cell-cycle analysis showed that M33-Meis1 impeded the progression of cells from G(1)-to-S phase, which correlated with significant reduction of cyclin D3 levels and the inhibition of retinoblastoma (pRb) hyperphosphorylation. We identified cyclin D3 as a direct downstream target of MEIS1 and M33-MEIS1 and showed that the G(1)-phase accumulation and growth suppression induced by M33-Meis1 was partially relieved by overexpression of cyclin D3. This study provides strong evidence linking the growth-promoting activities of Meis1 to the cyclin D-pRb cell-cycle control pathway.
  •  
3.
  • Russell, Bob, et al. (författare)
  • System, society and dominance effects in the adoption of tele-health: A tri-country comparison
  • 2017
  • Ingår i: Economic and Industrial Democracy. - 0143-831X .- 1461-7099. ; 38:3, s. 425-447
  • Tidskriftsartikel (refereegranskat)abstract
    • Although there have been many studies of low skilled call centre operators, research on professional workers in call centres is less common and cross-national research on such operations even rarer. This article compares the labour process experiences of tele-nurses – registered nurses in call centre settings – across three countries: the UK, Australia and Sweden. Using cross-national, comparative ethnographies, through a system, society and dominance (SSD) approach, the article explores the common problems tele-nurses face as well as distinctive societal differences in the ways in which this branch of e-health care is being established. The outcomes reveal both societal diversity and mounting pressures towards a globalizing conformity between the three countries with regard to the working practices of tele-nursing. The findings have important implications for whether or not a professional project can be developed around tele-health care.
  •  
4.
  • Olsson, Bob, 1969, et al. (författare)
  • Apolipoprotein C-I genotype and serum levels of triglycerides, C-reactive protein and coronary heart disease
  • 2010
  • Ingår i: Metabolism. - : Elsevier BV. - 0026-0495. ; 59:12, s. 1736-1741
  • Tidskriftsartikel (refereegranskat)abstract
    • Apolipoprotein C-I (apoCI) is implicated in lipid metabolism and inflammatory response, both important risk factors for human heart disease. However, most findings come from in vitro or animal studies, whereas data on human apoCI are sparse. To elucidate the role of apoCI in human disease, we analyzed a functional polymorphism in the promoter region of the apoCI gene in relation to blood lipids, C-reactive protein (CRP), coronary artery disease (CAD), and myocardial infarction (MI). Rs11568822 is a 4-base pair insertion/deletion (Ins/Del) polymorphism, and the Ins allele leads to a higher transcription in vitro compared with the Del allele. This polymorphism was analyzed in the Intergene study, a case-control study for CAD (N = 1236), and the Stockholm Heart Epidemiology Program, a case-control study for MI (N = 2774). Subjects homozygous for the Ins genotype had significantly higher serum levels of triglycerides (P = .01 and P = .006) and lower serum levels of CRP (P = .02 and P < .0001) compared with all other subjects in both studies. Similar results were obtained when analyzing only the controls of both studies (P = .002 and P = .0002, triglycerides; P = .002 and P < .0001, CRP). However, apoCI was not associated with CAD or MI. In conclusion, our data show that apoCI genotype is associated with serum levels of triglycerides and CRP, confirming the role of apoCI in lipid metabolism and suggesting that it also influences inflammation.
  •  
5.
  • Olsson, Bob, 1969, et al. (författare)
  • Biomarker-based dissection of neurodegenerative diseases.
  • 2011
  • Ingår i: Progress in neurobiology. - : Elsevier BV. - 1873-5118 .- 0301-0082. ; 95:4, s. 520-534
  • Forskningsöversikt (refereegranskat)abstract
    • The diagnosis of neurodegenerative diseases within neurology and psychiatry are hampered by the difficulty in getting biopsies and thereby validating the diagnosis by pathological findings. Biomarkers for other types of disease have been readily adopted into the clinical practice where for instance troponins are standard tests when myocardial infarction is suspected. However, the use of biomarkers for neurodegeneration has not been fully incorporated into the clinical routine. With the development of cerebrospinal fluid (CSF) biomarkers that reflect pathological events within the central nervous system (CNS), important clinical diagnostic tools are becoming available. This review summarizes the most promising biomarker candidates that may be used to monitor different types of neurodegeneration and protein inclusions, as well as different types of metabolic changes, in living patients in relation to the clinical phenotype and disease progression over time. Our aim is to provide the reader with an updated lexicon on currently available biomarker candidates, how far they have come in development and how well they reflect pathogenic processes in different neurodegenerative diseases. Biomarkers for specific pathogenetic processes would also be valuable tools both to study disease pathogenesis directly in patients and to identify and monitor the effect of novel treatment strategies.
  •  
6.
  • Olsson, Bob, 1969, et al. (författare)
  • Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet
  • 2005
  • Ingår i: Endocrinology. - : The Endocrine Society. - 0013-7227 .- 1945-7170. ; 146:2, s. 920-30
  • Tidskriftsartikel (refereegranskat)abstract
    • It is known that bovine GH (bGH) transgenic mice have increased body mass, insulin resistance, and altered lipoprotein metabolism when fed a normal diet (ND). In this study, the effects of 8 wk of high-fat diet (HFD) were investigated in 6-month-old male bGH mice. Although littermate controls had unchanged energy intake, energy intake was higher in the bGH mice on a HFD than on a low-fat diet. Nevertheless, the bGH mice were resistant to diet-induced weight gain, and only in the bGH mice did the HFD result in increased energy expenditure. Glucose oxidation was higher in the bGH mice compared with littermate controls on both a HFD and ND. In addition, the bGH mice had 0.5 C higher body temperature throughout the day and increased hepatic uncoupling protein 2 expression; changes that were unaffected by the HFD. On a HFD, the effect of bGH overexpression on serum triglycerides and apolipoprotein B was opposite to that on a ND, resulting in higher serum concentrations of triglycerides and apolipoprotein B compared with littermate controls. Increased serum triglycerides were explained by decreased triglyceride clearance. The HFD led to diabetes only in the bGH mice. In conclusion, bGH transgenic mice were resistant to diet-induced obesity despite hyperphagia, possibly due to increased energy expenditure. On a HFD, bGH mice became dyslipidemic and diabetic and thereby more accurately reflect the metabolic situation in acromegalic patients.
  •  
7.
  • Olsson, Bob, 1969, et al. (författare)
  • Cerebrospinal Fluid Levels of Heart Fatty Acid Binding Protein are Elevated Prodromally in Alzheimer's Disease and Vascular Dementia
  • 2013
  • Ingår i: Journal of Alzheimer's Disease. - 1387-2877 .- 1875-8908. ; 34:3, s. 673-679
  • Tidskriftsartikel (refereegranskat)abstract
    • Heart fatty acid binding protein (HFABP) is expressed in the brain and is elevated in cerebrospinal fluid (CSF) from patients with several forms of neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease with dementia, Lewy body dementia, vascular dementia (VaD), and Creutzfeldt-Jakob disease. However, whether HFABP in CSF is a stable biomarker or if it can help predict conversion from mild cognitive impairment (MCI) to AD or VaD has not been well studied. To address the role of HFABP in neurodegeneration, we analyzed CSF levels of HFABP in 96 AD patients and 65 controls and also in 170 patients with MCI with an average follow up time of 5.7 years. For the stability analysis, two CSF samples were collected from 52 AD patients with a six month interval in between. HFABP levels in CSF were very stable over the six month period (r = 0.93, p < 0.001). Furthermore, the CSF levels of HFABP were significantly elevated in AD compared with controls after adjustments for age and gender (p < 0.001). They were also elevated in the patients with MCI that subsequently converted to AD or VaD compared with those that remained stable (p < 0.001 and p < 0.05, respectively). However, ROC curve analysis showed that HFABP had lesser predictive value in determining conversion from MCI to AD and VaD than A beta(42), t-tau, and p-tau. In conclusion, HFABP seems to be a stable CSF biomarker that reflects neuronal cell death in several neurodegenerative disorders, including early stages of AD and VaD.
  •  
8.
  • Olsson, Bob, 1969, et al. (författare)
  • CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
  • 2016
  • Ingår i: The Lancet. Neurology. - 1474-4465. ; 15:7, s. 673-684
  • Tidskriftsartikel (refereegranskat)abstract
    • Alzheimer's disease biomarkers are important for early diagnosis in routine clinical practice and research. Three core CSF biomarkers for the diagnosis of Alzheimer's disease (Aβ42, T-tau, and P-tau) have been assessed in numerous studies, and several other Alzheimer's disease markers are emerging in the literature. However, there have been no comprehensive meta-analyses of their diagnostic performance. We systematically reviewed the literature for 15 biomarkers in both CSF and blood to assess which of these were most altered in Alzheimer's disease.
  •  
9.
  • Olsson, Bob, 1969, et al. (författare)
  • Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura.
  • 2005
  • Ingår i: Thrombosis and haemostasis. - 0340-6245. ; 93:1, s. 139-44
  • Tidskriftsartikel (refereegranskat)abstract
    • Idiopathic thrombocytopenic purpura (ITP) is an organ specific autoimmune disorder in which T-lymphocyte abnormalities have pathogenetic importance. In a DNA microarray screen of CD3+ T-lymphocytes from ITP patients and healthy controls we found an altered expression of genes associated with apoptosis, e.g. A20, caspase-8 and Bax. This together with our previous findings of increased gene expression of Fas, interferon-g and IL-2 receptor beta (IL2RB) indicated an altered activation induced cell death (AICD) of T-cells in ITP. Using a proliferation assay we found that CD3+ lymphocytes from ITP patients were significantly more resistant to dexamethasone induced suppression compared to normal lymphocytes. We also found that cultured CD3+ lymphocytes from ITP patients in remission were more susceptible to apoptosis both in the presence and absence of dexamethasone compared to cells from patient with active ITP and healthy controls, as indicated by increased staining of AnnexinV binding. Our findings suggest that apoptotic resistance of activated T-lymphocytes in patients with active ITP may lead to defective clearance of autoreactive T-lymphocytes through AICD, which might cause a continued immune destruction of platelets. Conversely, a loss of resistance to AICD in ITP patients in remission might be an important mechanism for the achievement of remission.
  •  
10.
  • Olsson, Bob, 1969, et al. (författare)
  • Extreme Stability of Chitotriosidase in Cerebrospinal Fluid makes it a Suitable Marker for Microglial Activation in Clinical Trials
  • 2012
  • Ingår i: Journal of Alzheimers Disease. - : IOS Press. - 1387-2877 .- 1875-8908. ; 32:2, s. 273-276
  • Tidskriftsartikel (refereegranskat)abstract
    • Microglia is thought to be important in Alzheimer's disease. Therefore, our aim was to investigate the usefulness of the microglial marker chitotriosidase in clinical trials. Chitotriosidase was analyzed in cerebrospinal fluid from Alzheimer's disease patients on acetylcholine esterase inhibitors (AChEI) and in cerebrospinal fluid from multiple sclerosis patients before and after natalizumab treatment. Chitotriosidase activity was extremely stable during treatment with the non-inflammatory drug AChEI. However, the immunomodulatory treatment with natalizumab led to lower chitotriosidase activity. Thus, chitotriosidase may be useful in clinical trials where microglia is targeted or as a safety biomarker in other trials where the brain is a bystander organ.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 116
Typ av publikation
tidskriftsartikel (102)
samlingsverk (redaktörskap) (3)
konstnärligt arbete (3)
forskningsöversikt (3)
konferensbidrag (2)
doktorsavhandling (1)
visa fler...
bokkapitel (1)
recension (1)
visa färre...
Typ av innehåll
refereegranskat (96)
övrigt vetenskapligt/konstnärligt (20)
Författare/redaktör
Olsson, Bob, 1969 (82)
Zetterberg, Henrik, ... (31)
Blennow, Kaj, 1958 (28)
Wadenvik, Hans, 1955 (25)
Jernås, Margareta, 1 ... (25)
Carlsson, Lena M S, ... (19)
visa fler...
Andreasson, Ulf, 196 ... (12)
Mattsson, Niklas, 19 ... (10)
Sjöholm, Kajsa, 1971 (8)
Nookaew, Intawat, 19 ... (8)
Portelius, Erik, 197 ... (7)
Malmeström, Clas, 19 ... (7)
Carlsson, Björn, 195 ... (7)
Jönsson, Sofia (7)
Lycke, Jan, 1956 (6)
Svensson, Per-Arne, ... (6)
Jacobson, Peter, 196 ... (6)
Sjöström, Lars (6)
Jacobsson, Stefan, 1 ... (6)
Hansson, Oskar (5)
Axelsson, Markus, 19 ... (5)
Palmqvist, Lars, 196 ... (5)
Bohlooly-Yeganeh, Mo ... (5)
Lautner, Ronald (5)
Gummesson, Anders, 1 ... (4)
Wallin, Anders, 1950 (4)
Ohlsson, Claes, 1965 (4)
Olsson, Maja, 1975 (4)
Thelle, Dag, 1942 (4)
Froguel, Philippe (4)
Palsdottir, Vilborg, ... (4)
Argiropoulos, Bob (4)
Kuchenbauer, Florian (4)
Heuser, Michael (4)
Humphries, R Keith (4)
Höglund, Kina, 1976 (4)
Törnell, Jan, 1960 (4)
Minthon, Lennart (3)
Landén, Mikael, 1966 (3)
Borén, Jan, 1963 (3)
Ahlin, Sofie, 1985 (3)
Gabrielsson, Britt, ... (3)
Cullen, Nicholas C (3)
Strandvik, Birgitta, ... (3)
Andreasen, Niels (3)
Yung, Eric (3)
Rudemo, Mats, 1937 (3)
Isaksson, Olle, 1943 (3)
Bjerke, Maria, 1977 (3)
Walley, Andrew (3)
visa färre...
Lärosäte
Karolinska Institutet (17)
Chalmers tekniska högskola (14)
Lunds universitet (10)
Uppsala universitet (4)
Umeå universitet (3)
visa fler...
Linköpings universitet (3)
Luleå tekniska universitet (1)
Högskolan Väst (1)
Högskolan i Skövde (1)
Högskolan i Borås (1)
Blekinge Tekniska Högskola (1)
visa färre...
Språk
Engelska (105)
Svenska (11)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (85)
Humaniora (10)
Naturvetenskap (9)
Samhällsvetenskap (7)
Lantbruksvetenskap (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy